Marapharm Ventures Inc. | Income Statement
Fiscal year is April-March. All values USD Thousands.
2014
2015
2016
2017
2018
Sales/Revenue
-
-
-
-
121.30
Cost of Goods Sold (COGS) incl. D&A
-
0.50
2.10
165.20
9,215.60
Gross Income
-
0.50
2.10
165.20
9,094.20
SG&A Expense
53.70
260.00
1,908.40
7,568.40
4,665.60
EBIT
53.70
260.50
1,910.50
7,733.60
13,759.80
Unusual Expense
82.40
3,807.80
591.00
-
1,128.50
Non Operating Income/Expense
-
-
-
292.50
44.30
Interest Expense
-
-
10.30
82.40
175.00
Pretax Income
28.70
4,068.30
2,511.80
7,523.50
15,016.30
Equity in Affiliates
-
-
-
85.20
1,028.60
Consolidated Net Income
28.70
4,068.30
2,511.80
7,608.70
16,044.90
Net Income
28.70
4,068.30
2,511.80
7,608.70
16,044.90
Net Income After Extraordinaries
28.70
4,068.30
2,511.80
7,608.70
16,044.90
Net Income Available to Common
28.70
4,068.30
2,511.80
7,608.70
16,044.90
EPS (Basic)
0.01
0.15
0.07
0.14
0.17
Basic Shares Outstanding
3,163.30
27,334.40
36,603.20
55,467.50
92,696.70
EPS (Diluted)
0.01
0.15
0.07
0.14
0.17
Diluted Shares Outstanding
3,163.30
27,334.40
36,603.20
55,467.50
92,696.70
EBITDA
53.70
260.00
1,908.40
7,568.40
13,538.30
Non-Operating Interest Income
-
-
-
-
2.70
About Marapharm Ventures
View Profile
